Human brain ferritin studied by muon Spin Rotation: a pilot study
Lucia Bossoni, Laure Grand Moursel, Marjolein Bulk, Brecht G. Simon,, Andrew Webb, Louise van der Weerd, Martina Huber, Pietro Carretta, Alessandro, Lascialfari, and Tjerk H. Oosterkamp

TL;DR
This pilot study uses Muon Spin Rotation to compare the magnetic properties of brain ferritin proteins from an Alzheimer's patient and a healthy individual, revealing differences in mineral composition and magnetic behavior.
Contribution
It introduces a novel application of Muon Spin Rotation to study brain ferritin and develops a model based on Néel superparamagnetism for interpreting spin relaxation data.
Findings
Healthy ferritins contain ferrihydrite-like minerals.
AD ferritins show crystalline phases possibly magnetite or maghemite.
Differences suggest altered mineralization in Alzheimer's disease.
Abstract
Muon Spin Rotation is employed to investigate the spin dynamics of ferritin proteins isolated from the brain of an Alzheimer's disease (AD) patient and of a healthy control, using a sample of horse-spleen ferritin as a reference. A model based on the N\'eel theory of superparamagnetism is developed in order to interpret the spin relaxation rate of the muons stopped by the core of the protein. Using this model, our preliminary observations show that ferritins from the healthy control are filled with a mineral compatible with ferrihydrite, while ferritins from the AD patient contain a crystalline phase with a larger magnetocrystalline anisotropy, possibly compatible with magnetite or maghemite.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Human-brain ferritin studied by muon Spin Rotation: a pilot study
Lucia Bossoni1, Laure Grand Moursel2,3, Marjolein Bulk2,3,4, Brecht G. Simon1, Andrew Webb3, Louise van der Weerd2,3, Martina Huber1, Pietro Carretta5, Alessandro Lascialfari6, Tjerk H. Oosterkamp1
1Huygens-Kamerlingh Onnes Laboratory, Leiden University, 2333 CA Leiden, The Netherlands
2Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
3Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
4Percuros BV, Leiden, The Netherlands
5Department of Physics, Pavia University, Pavia, Italy
6Dipartimento di Fisica, Università Degli Studi di Milano, Milano, Italy
Abstract
Muon Spin Rotation is employed to investigate the spin dynamics of ferritin proteins isolated from the brain of an Alzheimer’s disease (AD) patient and of a healthy control, using a sample of horse-spleen ferritin as a reference. A model based on the Néel theory of superparamagnetism is developed in order to interpret the spin relaxation rate of the muons stopped by the core of the protein. Using this model, our preliminary observations show that ferritins from the healthy control are filled with a mineral compatible with ferrihydrite, while ferritins from the AD patient contain a crystalline phase with a larger magnetocrystalline anisotropy, possibly compatible with magnetite or maghemite.
pacs:
75.20.-g, 75.30.Gw, 75.75.Jn,76.75.+i,87.80.Lg
Keywords: muon Spin Rotation, nanomagnetism, ferritin, Alzheimer’s disease
1 Introduction
Ferritin is a protein that attracts much interest, not only because of its crucial role in iron storage and ferroxidase activity [1, 2], but also because of its magnetic properties. Ferritin is a nanoscopic hollow protein made of a shell (apoferritin) of molecular weight 450 kDa, containing a core of trivalent iron (Fe(III)) in the mineral form of ferrihydrite, a nano-crystal quite elusive to X-ray diffraction. Ferritin acquires Fe(II), catalyzes iron oxidation, and induces mineralization within its cavity [3]. The outer diameter of the shell is 12 nm, regardless of the iron loading, whereas the iron core diameter can vary between 2-3 nm and 7 nm [4], depending on the number of stored ions.
It is generally agreed that the ferritin core is antiferromagnetic (AFM) below a temperature in the range of 340-500 K [4, 5, 6]. However, some AFM sublattices do not cancel out completely due to the small particle size. This results in an excess of spin orientation, giving rise to a magnetic moment of 225-400 [7, 4, 8]. Because of its hexagonal crystal structure (space group ), the particle possesses a unique easy axis of magnetization [9]. The ”giant” magnetic moment of the particle can rotate about the crystal easy axis, if it overcomes an energy barrier , which depends on the volume of the particle V and on the magnetocrystalline anisotropy constant, K [10]. If, upon decreasing the temperature, the dynamic time constant of the moment crossing the barrier () is greater than the measuring time of the specific experimental technique (), the magnetic moment is said to be blocked [11]. This formalism was introduced by Néel to describe the magnetism of nanoscopic single-domain particles with an internal magnetic order. The magnetic behaviour of an assembly of these ultra-fine particles was termed superparamagnetism (SPM). This blocking occurs at about 12 K, for ferritin, when s [12], in a DC magnetometry measurement. In addition to the AFM and SPM phases, it was also proposed that a Curie-Weiss-like behavior could be found at the core-shell interface, as a result of the reduced Weiss field [7, 10]. More recently, other models have been proposed, yet the exact spin structure of the nanoparticle and its magnetic properties are still a matter of debate [7, 13, 4, 8].
Ferritin has also been extensively studied by neuroscientists, due to its central role in cellular iron homeostasis. Ferritin is at the center of many debates concerning iron toxicity in relation to neurodegeneration, and in particular to Alzheimer’s disease (AD). In the brain of AD patients, iron dis-regulation has been reported [14]. This may indicate a malfunction of the storage protein [15], leading to oxidative stress via Fenton and Haber-Weiss reactions [1, 16, 17, 18]. Microscopy studies revealed the existence of ferritins with a poly-phasic structure: ferritins found in the brain of AD patients seem to contain a higher amount of cubic crystalline phases consistent with magnetite and wüstite [19, 20], whereas the ’healthy type’-ferritins may be more abundant in the hexagonal ferrihydride phase. In this scenario, pathological ferritin would be better described by magnetoferritin, an artificial complex made of apoferritin containing a magnetite or maghemite crystal [21]. However, these observations were not confirmed by nuclear magnetic resonance (NMR) [22]. Since magnetoferritin carries a larger magnetic moment than ferrihydrite, i.e. typically between 2000 and 9000 [23], one would expect a 200-fold (or larger) increase in the longitudinal and transverse relaxation rates of the water protons surrounding the protein. However, no significant enhancement of the relaxation rate was observed.
Additionally, Pan et al. showed that in human-liver ferritin, an increasing percentage of octahedrally coordinated Fe(III) migrated to tetrahedral sites and was partially reduced to Fe(II), upon increasing the electron dose in electron microscopy experiments [24]. Although it is rather unlikely that such alterations would happen only on the ’pathological’ ferritin [25], the poly-phasic composition of physiological versus pathological ferritins remains a debated issue. In order to unravel these controversies, here we propose a muon Spin Rotation (SR) experiment, as an alternative investigation technique.
SR has been successfully employed in the past to study the magnetism of fine-particles systems. In particular, horse-spleen ferritin [26, 27] and similar artificial compounds [28] have shown a two-component relaxation of the muon Asymmetry: while the fast-decaying Asymmetry (exponential- or Kubo-Toyabe-like) reflects the static order/collective excitation and the superparamagnetism of the iron core occurring respectively below and above the blocking temperature (), the slow exponential tail has been ascribed to the interaction of the muon spin with the protons of the organic shell. However, a study of ferritin purified from human tissue has not been undertaken yet.
In this manuscript, we present a SR study of a ferritin sample isolated from the brain of an AD patient, and an age- and gender-matched healthy control (HC). As a third sample and reference, a lyophilized commercial horse-spleen ferritin sample (HoSF) was used. Firstly, we evaluate the feasibility of SR on a human sample. Then we propose a model to interpret the spin dynamics of the ferritin iron core, associated with the SPM effect. Secondly, we draw some preliminary conclusions on the mineral composition of the protein core based on the magnetocrystalline anisotropy constant derived from our model, showing that all steps of the analysis are feasible. Finally, we discuss the limitations and the improvements that should be undertaken in future studies.
2 Sample preparation and characterization
One freshly frozen human-brain hemisphere from an AD case (Braak stage 6C, age 90 yrs, female) and one from a healthy age- and gender-matched control (age 88 yrs, female) were obtained from the Netherlands Brain Bank (NBB) of Amsterdam. Patient anonymity was strictly maintained and informed consent was obtained from all prospective donors by NBB in accordance with EU regulations. All tissue samples were handled in a coded fashion, according to Dutch national ethical guidelines (Code for Proper Secondary Use of Human Tissue, Dutch Federation of Medical Scientific Societies).
Before the tissue was processed for protein isolation, a section from the temporal region was selected from both the AD and the control individual for an MRI study (see Supplementary Information). Ferritin used in the SR experiment was isolated from 2/3 of the hemispheres of the two individuals by following a modified version of the method reported by Cham et al. [29]. The original protocol requires only a few steps and it is practical when dealing with a large amount of brain material. Moreover, this method retains most of the iron inside the protein, that is our main concern in this experiment. One part of the brain was homogenized on ice with three parts of Phosphate-buffered saline solution (PBS), with a tissue homogenizer (Omni B style TH Motor 220 V, LA Biosystems). Subsequently, the nuclei and unbroken cells were removed by low-speed centrifugation: 2000 g for 15 min, at 4 *∘*C. The supernatant was retained and put on ice again. This solution was further diluted with pure methanol 99.8% (J. T. Baker, product num.: 8045.2500) in order to reach a final concentration of 40 % v/v. This new solution was heated for 10 minutes at 75 *∘*C, and afterward put on ice again, and finally centrifuged at 2000 g for 15 min, at 4 *∘*C. The ferritin-containing supernatant (final volume: 1.5-2 liters) was retained in order to be further purified, desalted and concentrated with an Amicon Ultra-15 Centrifugal Filter Unit with an Ultracel-100 membrane (UFC910008) with a molecular cutoff of 100 kDa. Aliquots of the supernatants were assayed for ferritin by SDS gel electrophoresis, Western Blot, and Transmission Electron Microscopy. The remaining solution was freeze-dried for the magnetic characterization. In order to prevent contamination with magnetic material, no metal tools or containers were used in the dissection and handling of the tissue. Ceramic and plastic materials were used instead.
SDS-gel electrophoresis was done in parallel to Western Blot analysis: the results show the presence of both ferritin sub-bands in the human samples (Fig. 1).
One part of the gel was stained to assess purity and protein concentration, while the other part was used for Western Blot to determine the presence and molecular weight of ferritin. Protein solutions were loaded on the lanes of a 4-20% Criterion TGXTM pre-cast gel purchased from Bio-Rad. As a reference, Precision Plus ProteinTM Dual Xtra Prestained Protein Standards (product num.: 1610377) and ferritin from equine spleen purchased from Sigma-Aldrich (productr num.: F4503) were employed. Horse-spleen ferritin was loaded as a reference sample in three different concentrations. The gel was run using a standard Laemmli sample buffer and Tris/glycine/SDS running buffer. The gel was stained with PageBlueTM protein staining solution (ThermoFisher Scientific, product num. 24620) and imaged with the Li-Cor OdysseyTM imaging system. The human ferritin concentration was estimated from the heavy and light chain bands: 227.3 g/g for the AD sample and 210.5 g/g for the HD. Taking into account the solution volume after the concentration step, and the powder obtained after freeze-drying, we estimated that the ferritin concentration loaded onto the SR sample holder was 11 % and 14.3 % of the total sample mass for the AD and HC ferritin, respectively. However, a spread of values in the concentration of different batches cannot be excluded.
The presence of ferritin was verified by Western Blot. Anti-human-ferritin goat antibody NBP1-06985 purchased from Novus Biologicals was used as a primary antibody. Fluorescent donkey antigoat antibody was used as a secondary antibody. Antibody solutions and blocking solutions were prepared with tris-buffered saline Tween (TBST) and non-fat 5% powder milk. The nitrocellulose membrane was imaged with the same Li-Cor OdysseyTM imaging system.
In order to confirm the presence of the ferritin iron core, we performed Transmission Electron Microscopy (TEM) on the purified protein solution. TEM images were acquired using a JEOL 1010 Transmission Electron Microscope, at 70 kV. A 10 -solution containing human-brain ferritin was drop-cast on a carbon coated copper grid (200 mesh, Van Loenen Instruments) and let dry for a few minutes. The solution that did not absorb into the grid was removed with dust-free paper. The ferritin solution obtained after the isolation protocol was imaged before freeze-drying (Fig. 2) and later the freeze-dried powder used for the experiment was re-suspended in milliQ water and imaged with the same protocol. No appreciable changes in the iron core size distribution, as a result of freeze-drying and SR experiments, were observed (data not shown). Fig. 2 shows dark dots of electron-dense material indicating the iron-filled ferritin cores. The size distribution of the ferritin particles, obtained by the analysis of several TEM micrographs, follows a log-normal curve. Moreover, our results suggest that the AD ferritins have a smaller core size, with a mean of 4.39 nm and a standard deviation of 2.17 nm, than the HC ferritins which show a mean-core size of 6.64 nm and a standard deviation of 3.11 nm. These values are reasonably in agreement with the literature [30]. No larger, i.e. several tens of nm, particles were found in the analyzed solution by TEM inspection.
Freeze-dried powders of human-brain ferritin were characterized with a 7 T-MPMS SQUID magnetometer. In these experiments, the static spin susceptibility is measured at 50 G after cooling the sample in two different ways. In the Zero-Field-Cooled (ZFC) case, the sample is cooled from room temperature, down to 2 K without applying a magnetic field. Then the field is increased to 50 G and the static susceptibility is measured. In contrast, in the Field-Cooled (FC) case, the sample is cooled with the field of 50 G applied continuously. The static spin susceptibility () of the human ferritin samples is shown in Fig. 3. The ZFC shows the typical peak of a superparamagnet after subtracting a Curie-Weiss trend from the data [31, 12] (inset Fig. 3). The AD sample shows a broad peak, centered around 8.8 0.9 K, indicating a blocking temperature () smaller than that observed in the HoSF sample (12 1 K, data are shown elsewhere [32]). of the HC sample is the same as the HoSF sample. These values of suggest that the average core size of the AD sample is smaller than the one of the healthy control and horse-spleen samples. This observation is in agreement with the TEM characterization. Please note that the FC curve does not show this peak, as 50 G is enough to block the superparamagnet at low temperatures. Furthermore, the presence of a peak in the ZFC curve in the range of 9-12 K rules out the possibility that a substantial part of our sample contains magnetite particles of tens of nm [33, 34, 35, 32].
Finally, the presence of iron in all the powder samples was confirmed by Laser-ablation Inductively coupled Mass spectrometry.
3 Results
Ferritin powders of different origin were loaded onto a kapton holder, with a thin (25 m) kapton window to allow the muons to reach the sample. Experiments were carried out in longitudinal geometry, both in Zero-Field and longitudinal field mode. The experiments were performed at the GPS beamline of the Paul Scherrer Institute, where a continuous wave (CW) muon beam is available. CW muons allow a high time resolution, which in turn enables strongly inhomogeneous internal fields to be probed. A forward and a backward detector were used at all times. The time-dependent Asymmetry A(t) function is calculated as:
[TABLE]
where F(t) and B(t) are the positron counts in the forward and backward detector respectively, while is an instrumental parameter which compensates for the difference in efficiency between the two detectors. Our estimated ranged between 0.787 and 0.859 and it was calibrated in a transverse field of 50 G, at high temperature (170 K). Data were bunched with the ’Constant error’ binning option of the Wimda software, in which the bin length exponentially increases with time from the initial value so that the counts per bin and the resulting error remained fixed. Data were fitted between 0 and 6 . Different fitting functions were tested, such as the Uemura function [36], various combinations of Lorentzian and Gaussian Kubo-Toyabe [37]. The dynamical Kubo-Toyabe and Keren functions [38] were also tested, but they could not capture all the features of the data, as the empirical model discussed in this manuscript. Muon Spin Rotation raw data were processed with Wimda, and fitted with Wimda, Matlab 2016a and OriginLab(R) Pro 2016.
3.1 Horse-spleen ferritin Zero-Field Asymmetry
Before carrying out the SR study on the human-brain ferritin, a sample of freeze-dried horse-spleen ferritin was investigated. Horse-spleen ferritin was chosen because it is similar to human ferritin and therefore a good reference. Zero-Field SR on HoSF shows a change in the muon Asymmetry decay as a function of the temperature (Fig. 4).
We observed an initial Asymmetry () of 15 %, which equals 2/3 of the full Asymmetry. This signal loss will be discussed later in this section.
In the Zero-Field measurement data, two regimes were identified. At temperatures higher than 20 K, the Asymmetry is well described by the sum of two contributions, namely an exponential term, decaying in the first 300-500 ns, and a slower stretched-exponential component, evolving from a Gaussian at high temperature, to a single exponential at low temperature. The decay of was modeled by assuming that a fraction of muons probes the local magnetic field of the protein shell (), and the rest probes the core ():
[TABLE]
We observed a fraction ratio of . A similar value was found by Cristofolini et al., who suggested that such a fraction may originate from the core/shell mass ratio [26]. If we consider the mean values for the diameter of the core (5-6 nm) and of the shell (12 nm), we would expect to observe , instead. The discrepancy was ascribed to conformational changes of the protein shell, as suggested for example for freeze-dried proteins [39]. Note that the experimental ratio could be different also because the muon implantation is not random.
In Eq. 2, represents the spin-lattice relaxation rate of the ’core muons’, analogous to the NMR [40, 41]. As it will be shown, the fast decaying component is weakly dependent on the application of a longitudinal magnetic field. Finally, is the spin relaxation rate of the muons probing the protein shell, and the stretched exponent in Eq. 2 can be associated with either a distribution of muon sites or with an anisotropic hyperfine coupling, leading to a distribution of relaxation rates.
Below 20 K, the Asymmetry shows an increase at times longer than 4 s (Fig. 4), indicating the onset of a static magnetic phase. We note that in contrast to the work of Cristofolini et al. on HoSF [26], here the Gaussian decay is not reached at any temperature below 20 K. The best fit to the data was obtained by adding a slow oscillating term, with a small amplitude ( 6%):
[TABLE]
where the baseline was deduced from the high-temperature regime, rad is the muon gyromagnetic ratio, is the local field probed by the muons, is a phase constant and represents the fraction of ’shell muons’ probing static magnetism. The internal field of 8 G, at low temperature (Fig. 4 (inset)) can be explained in terms of the local dipolar field produced by blocked iron magnetic moments of 5 , at an average distance of 1.8 nm from the muon implantation site (See the Supplementary information for a more detailed description of the fitting). This internal field is of the same order of magnitude as that derived by Cristofolini et al. [26], on horse-spleen ferritin, at low temperature.
3.2 Human-brain ferritin Zero-Field Asymmetry
The Asymmetry decay of the human-brain ferritin is remarkably similar to that of HoSF, as far as the high-temperature limit is concerned (Fig. 5), therefore we fitted the data with the high-temperature model of Eq. 2. However, by a more careful inspection of the data, some differences can be observed between the human and the horse data sets. The most remarkable are that the human ferritin Asymmetry does not increase at long times and at low temperature, as described by Eq. 3. This may be due to the lower ferritin concentration in the human sample. Secondly, the stretched exponent does not decrease below 1.4 in both human samples, showing that the mono-exponential limit, in the slow terms, is never reached (Fig. 6). Finally, the initial Asymmetry of the human data is smaller than in the HoSF data (Fig. 5), as it will be discussed in the next section.
Fig. 6 summarizes the best-fit parameters for the relaxation rates () and stretched exponent (), as a function of the temperature, for the three samples. The Asymmetry decay of human ferritins was described by a model with three fitting parameters, while the ratio of the core-shell muon fraction was fixed. The baseline was also left free to vary, but it did not show significant variations with the temperature.
3.3 Longitudinal SR field measurements on human-brain and horse-spleen ferritin
Longitudinal-Field (LF) SR on the horse and human ferritin show two effects in the muon Asymmetry. Firstly, the application of a weak field enhances the initial Asymmetry , as also observed by other authors in a HoSF sample [26, 27]. Secondly, the stretched exponential relaxation is partially quenched by the longitudinal field (Fig. 7). The loss of was earlier ascribed to muonium formation (a radioactive isotope of hydrogen) after the captures an electron, as often occurs in organic matter and in polymers [42, 43]. In this case, the polarization can be fully recovered by the application of a longitudinal magnetic field, large enough to decouple the hyperfine interaction between the electron and the muon. Given the large amount of organic material in our sample and the partial recovery of with the application of an LF, it is reasonable to assume that the signal loss at is due to muonum formation. Moreover, since the human sample is about seven times more dilute than the HoSF, one may ascribe the larger loss of initial Asymmetry to a larger fraction of other proteins in the human sample (Fig. 5).
The quenching of the stretched exponential relaxation by small fields is in agreement with the hypothesis that this decay originates from the muons implanting in the protein shell, and probing weak dipolar fields of the proton nuclei. Moreover, the fast exponential term is not affected by the LF, thus suggesting that in this case, the local field is either static and strong (i.e. a few Tesla) or dynamic, as expected for the iron core.
4 Discussion
Among the different magnetic resonance techniques, muon Spin Rotation benefits from an almost 100 % spin-polarized muon beam, leading to a signal which is not limited by the Boltzmann polarization. Since the spin probe (the muon itself) is implanted into the sample, the technique is neither limited by the sensitivity nor by the natural abundance of the internal probe, as it is in the case of NMR. Additionally, the signal intensity is not dependent on the strength of the external magnetic field. In SR, Zero-Field experiments are possible and the muon current is so small ( pA) that no or minor sample damage is expected.
Moreover, muon Spin Rotation offers several advantages for the study of nanoscopic magnetic systems: it directly probes the stray field produced by the metallic nanoparticle, and it captures its spin dynamics in a broad dynamic range (between 10*-12* s and 10*-5* s). On the other hand, obtaining structural information from relaxation rates still remains a challenge. In the next section, we propose a model to interpret the spin-lattice relaxation rate of the muon fraction stopping in the iron core of the protein ().
There are at least two channels for the spin relaxation of muons implanting in ferritin: (i) spin excitations of the AFM ordered lattice, which would appear at low temperatures, in the form of a power law [44, 45] and (ii) Néel relaxation of the particle giant moment, activated by thermal energy. The correlation time for the latter spin fluctuations is typically described by the Néel-Arrhenius relation, for non-interacting particles [11]:
[TABLE]
where is the attempt frequency, [46, 47] is the energy barrier, and is the Boltzmann constant. Such jumps of the particle magnetic moment are random between opposite values, therefore the spin-spin correlation function becomes [48]:
[TABLE]
Hence, one can borrow the formalism from the NMR theory of the spin-lattice relaxation rate, for a mono-dispersed particle distribution [40]:
[TABLE]
where is the static rms value of the hyperfine field, and is the local field probed by the muons implanting in the core [49]. Since the ferritins’ diameters are log-normally distributed, as observed by TEM, Eq. 6 should be integrated over the volume distribution:
[TABLE]
where and are respectively the standard deviation and the mean of the log-normal distribution.
In order to interpret , we choose and from literature values for ferrihydrite (see Fig. 8 and its caption).
The simulation in Fig. 8 (a) shows that particles with a larger volume (as observed for HC) display a peak in at higher temperature, and that particles with a broader particle-size distribution display a broader peak in . Fig. 8 (b) shows a positive correlation between the value of and the temperature of the peak in . Here, instead of choosing one single value for , we present a range of values, as reported in literature. Indeed, depends on several factors such as chemical composition, kind of magnetic ion, particle shape, amount of frustrated spins at the particle surface, distribution of nucleation sites inside the core, and level of crystallinity. Plausible values for , in the case of the ferrihydrite mineral, range from 0.7 to 2.5 K/nm3 [51, 52, 53], while for magnetoferritin, and magnetite nanoparticles they can be found between 2.7 and 9.7 K/nm3 or higher [54, 21]. However, intermediate values of 2.97 K/nm3 have also been measured for HoSF [50]. In Fig. 8 (b) the chosen values are limited to 7.7 K/nm3, for illustration purposes. Moreover, in all the following simulations, has been fixed to 8 G. This assumption, based on the experimental observation on the HoSF data, may be an over-simplification in the case of the human data.
A comparison between the experimental and simulated is shown in Fig. 9, for the three investigated samples.
All the samples show a broad peak in , in the same temperature range observed in other works on HoSF and its synthetic analogues [26, 28]. In the case of HoSF, the acceptable values for fall between 2.5 and 2.7 Knm3 (Fig. 9 (a)), which is in line with the literature findings for HoSF, as discussed above. We note that may be overestimated, if the actual mean particle size was larger than considered here. The HC sample shows a broader peak centered in a temperature region compatible with Knm3, which suggests the presence of a single ferrihydrite phase (Fig. 9 (c)), in agreement with the expectations for ferrihydrite and possibly characterized by a lower degree of crystallinity with respect to the HoSF. Finally, the AD sample shows a narrower peak in , which results from a narrower particle-size distribution (Fig. 9 (b)), and a significantly larger anisotropy constant of Knm3, corresponding to a 63 % increase of the magnetic anisotropy, which is more than what can be expected from a difference in particles size between AD and HC [54]. This constant falls in the experimentally observed range of magnetoanisotropy for magnetoferritin nanoparticles.
It is worth stressing that this is the first attempt to use muon Spin Rotation to determine the mineralization form of the ferritin-iron core in human-brain ferritin, as a complementary tool to electron microscopy. Therefore, in order to improve the current data, and confirm our preliminary results, the human ferritin concentration and purity should be improved. A possibility would be to add a further purification step, such as affinity chromatography, at the end of our protocol. As many of these steps can be further improved, future experiments are certainly feasible and will be sensitive enough to determine differences with greater accuracy.
5 Conclusions
We isolated ferritin from the brain of an AD patient and a healthy age- and gender-matched individual. The protein solution was characterized by biochemical and physical techniques assessing the protein concentration and verifying the superparamagnetic properties, and the presence of iron in the sample. The characterization shows that the isolation protocol needs further improvements, in order to significantly increase the concentration and purity of the ferritin solution.
SR was then used to probe the spin dynamics of the iron core of human-brain ferritin, as a function of the temperature. Our pilot experiment showed Asymmetry spectra that significantly resembled those of commercial and highly pure horse-spleen ferritin, which was used as a reference in this study. A broad peak in the spin-lattice relaxation rate of the muons stopping in the core allowed us to identify the blocking temperature of ferritin. We proposed a model to interpret the spin-lattice relaxation rate, based on the Néel theory of superparamagnetism, and on the experimental size distribution of the obtained ferritin particles. The comparison between simulation and experimental data gave us an indication of the magnetocrystalline anisotropy constant of the ferritin iron core. Our analysis suggests that ferritin isolated from the control subject is in agreement with a mineral phase compatible with ’physiological’ ferrihydrite, while the ferritin isolated from the Alzheimer’s patient contains an iron mineralization form with a larger constant, in the range observed for magnetoferritin, when the size distribution obtained from electron microscopy is taken into account. However, to draw further conclusions about the composition of ferritin in relation with AD, ferritin isolated from different AD patients should be investigated. This pilot study shows that SR is a promising approach to the study of iron-loaded human-brain proteins.
Acknowledgements
We are grateful to M. de Wit, A. Amato and C. Baines for proving help during the muon Spin Rotation experiment and for useful discussion. We thank L. Cristofolini and J. Wagenaar for fruitful discussions. G. Lamers, J. Willemse, L. van der Graaf, J. Aarts, N. Lebedev and C. Koeleman for technical assistance during ferritin freeze-drying and characterization. We thank W. Breimer for helping during the MRI data acquisition.
This work was supported by the Dutch Foundation for Fundamental Research on Matter (FOM), by the Netherlands Organization for Scientific Research (NWO) through a VICI fellowship to T. H. O. and through the Nanofront Program. One of us (M. B.) was supported by the FP7 European Union Marie Curie IAPP Program, BRAINPATH, under grant number 612360. Partial funding was provided by European Research Council, Advanced Grant 670629 NOMA MRI.
References
- [1]
Ward R J, Zucca F A, Duyn J H, Crichton R R and Zecca L 2014 The Lancet Neurology 13 1045 – 1060
- [2]
Yang X and Chasteen N D 1999 The Biochemical journal 338 (Pt 3) 615–618
- [3]
Chasteen N D and Harrison P M 1999 Journal of structural biology 126 182–194
- [4]
Gilles C, Bonville P, Rakoto H, Broto J M, Wong K K W and Mann S 2002 Journal of Magnetism and Magnetic Materials 241 430–440
- [5]
Jang Z H, Suh B J, Lascialfari A, Sessoli R and Borsa F 2000 562 557–562
- [6]
Brem F, Stamm G and Hirt A M 2006 Journal of Applied Physics 99 123906
- [7]
Brooks R A, Vymazal J, Goldfarb R B Bulte J W M and Aisen P 1998 Magnetic Resonance in Medicine (40) 227–235
- [8]
Papaefthymiou G C 2010 BBA - General Subjects 1800 886–897
- [9]
Michel F M, Ehm L, Antao S M, Lee P L, Chupas P J, Liu G, Strongin D R, Schoonen M A A, Phillips B L and Parise J B 2007 Science 316 1726–1729
- [10]
Néel L 1961 Comptes rendus 252 4075
- [11]
Dormann J L, Fiorani D and Tronc E 1997 Advances in Chemical Physics XCVIII 283
- [12]
Makhlouf S A, Parker F T and Berkowitz A E 1997 Physical Review B 55 R14717–R14720
- [13]
Silva N J O, Millán A, Palacio F, Kampert E, Zeitler U, Rakoto H and Amaral V S 2009 Physical Review B - Condensed Matter and Materials Physics 79 1–7
- [14]
Goodman L 1953 J. Nerv. Ment. Dis. 118 97
- [15]
Dobson J 2001 FEBS Letters 496 1–5 ISSN 00145793
- [16]
Valko M, Jomova K, Rhodes C J, Kuča K and Musílek K 2016 Archives of toxicology 90 1–37
- [17]
Núñez M T, Urrutia P, Mena N, Aguirre P, Tapia V and Salazar J 2012 BioMetals 25 761–776
- [18]
Crichton R 2009 Iron metabolism: from molecular mechanisms to clinical consequences (John Wiley & Sons)
- [19]
Quintana C, Cowley J and Marhic C 2004 Journal of Structural Biology 147 166–178
- [20]
Quintana C, Bellefqih S, Laval J, Guerquin-Kern J, Wu T, Avila J, Ferrer I, Arranz R and Patiño C 2006 Journal of Structural Biology 153 42 – 54 ISSN 1047-8477
- [21]
Moro F, de Miguel R, Jenkins M, Gómez-Moreno C, Sells D, Tuna F, McInnes E, Lostao A, Luis F and van Slageren J 2014 Journal of Magnetism and Magnetic Materials 361 188 – 196
- [22]
Gossuin Y, Hautot D, Muller R N, Pankhurst Q, Dobson J, Morris C, Gillis P and Collingwood J F 2005 NMR in biomedicine 18 469–72
- [23]
Dutta P, Manivannan A, Seehra M S, Shah N and Huffman G P 2004 Phys. Rev. B 70(17) 174428
- [24]
Pan Y, Brown A, Brydson R, Warley A, Li A and Powell J 2006 Micron 37 403–411
- [25]
Quintana C and Gutiérrez L 2010 Biochimica et Biophysica Acta - General Subjects 1800 770–782
- [26]
Cristofolini L, Prassides K, Vavekis K, Amato a, Gygax F N, Schenck a, Giderc S and Awschalomc D 1997 Hyperfine Interactions 104 269–274
- [27]
Telling M T and Kilcoyne S H 2012 Physics Procedia 30 86–90
- [28]
van Lierop J, Ryan D, Pumarol M and Roseman M 2001 Journal of Applied Phisics 89 7645–7647
- [29]
Cham B E, Roeser H P, Nikles a and Ridgway K 1985 Analytical biochemistry 151 561–5
- [30]
Gálvez N, Fernández B, Sánchez P, Cuesta R, Ceolín M, Clemente-León M, Trasobares S, López-Haro M, Calvino J J, Stéphan O and Domínguez-Vera J M 2008 Journal of the American Chemical Society 130 8062–8068
- [31]
Brem F, Tiefenauer L, Fink A, Dobson J and Hirt A 2006 Physical Review B 73 1–6
- [32]
Kumar P, Bulk M, Webb A, van der Weerd L, Oosterkamp T H, Huber M and Bossoni L 2016 Scientific Reports 6
- [33]
Kirschvink J L, Kobayashi-Kirschvink a and Woodford B J 1992 Proceedings of the National Academy of Sciences of the United States of America 89 7683–7687 ISSN 0027-8424
- [34]
Maher B A, Ahmed I A M, Karloukovski V, MacLaren D A, Foulds P G, Allsop D, Mann D M A, Torres-Jardón R and Calderon-Garciduenas L 2016 Proceedings of the National Academy of Sciences 113 10797–10801
- [35]
Pankhurst Q, Hautot D, Khan N and Dobson J 2008 J Alzheim Dis 13 49–52
- [36]
Uemura Y J, Yamazaki T, Harshman D R, Senba M and Ansaldo E J 1985 Physical Review B 31 546–563
- [37]
Kubo R and Toyabe T 1967 Magnetic Resonance and Relaxation (North-Holland, Amsterdam)
- [38]
Keren A 1994 Physical Review B 50 10039–10042
- [39]
Roy I and Gupta M N 2004 Biotechnology and Applied Biochemistry 39 165–177
- [40]
Lee S L, Kilcoyne S H and Cywinski R 1999 Muon Science. Muons in Physics, Chemistry and Materials (SUSSP Publications and Institue of Physics Publishing)
- [41]
Carretta P, Lascialfari A et al. 2007 NMR-MRI, muSR and Mössbauer Spectroscopies in Molecular Magnets (Springer-Verlag Italia)
- [42]
Blundell S J, Pattenden P A, Pratt F L, Valladares R M, Sugano T and Hayes W 1995 EPL (Europhysics Letters) 31 573
- [43]
Pratt F L, Blundell S J, Hayes W, Nagamine K, Ishida K and Monkman A P 1997 Phys. Rev. Lett. 79(15) 2855–2858
- [44]
Beeman D and Pincus P 1968 Phys. Rev. 166(2) 359–375
- [45]
Bossoni L, Carretta P, Nath R, Moscardini M, Baenitz M and Geibel C 2011 Phys. Rev. B 83(1) 014412
- [46]
Silva and coworkers state that in ferritin the energy barrier is proportional to the square root of the particle volume (see Ref. 47). The effective anisotropy they derived for particles of size 1-10 nm ranges from 1.086 K/nm3 to 3.4 K/nm3, slightly larger than what reported here as reference values for ferrihydrite. However, in order to be able to compare our estimated with former results, we have used here the common-expression .
- [47]
Silva N J O, Amaral V S, Carlos L D, Rodriguez-Gonzalez B, Liz-Marzan L M, Berquo T S, Banerjee S K, Bermudez V D, Millan A and Palacio F 2008 Physical Review B 77 134426
- [48]
Slichter C P 1995 Principles of Magnetic Resonance (Springer-Science and Business Media)
- [49]
Arosio P, Corti M, Mariani M, Orsini F, Bogani L, Caneschi A, Lago J and Lascialfari A 2015 Journal of Applied Physics 117 17
- [50]
Madsen D E, Hansen M F, Bendix J and Mørup S 2008 Nanotechnology 19 315712
- [51]
Schäfer-Nolte E, Schlipf L, Ternes M, Reinhard F, Kern K and Wrachtrup J 2014 Phys. Rev. Lett. 113(21) 217204
- [52]
Gunther L and Barbara B 1995 Proceedings of the NATO Advanced Research Workshop in Quantum Tunneling of Magnetization — QTM ’94, (Springer Science+Buisness Media Dordrecht)
- [53]
Li H, Klem M T, Sebby K B, Singel D J, Young M, Douglas T and Idzerda Y U 2009 Journal of Magnetism and Magnetic Materials 321 175 – 180
- [54]
Martínez-Pérez M J, de Miguel R, Carbonera C, Martínez-Júlvez M, Lostao A, Piquer C, Gómez-Moreno C, Bartolomé J and Luis F 2010 Nanotechnology 21 465707
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1[1] Ward R J, Zucca F A, Duyn J H, Crichton R R and Zecca L 2014 The Lancet Neurology 13 1045 – 1060
- 2[2] Yang X and Chasteen N D 1999 The Biochemical journal 338 (Pt 3) 615–618
- 3[3] Chasteen N D and Harrison P M 1999 Journal of structural biology 126 182–194
- 4[4] Gilles C, Bonville P, Rakoto H, Broto J M, Wong K K W and Mann S 2002 Journal of Magnetism and Magnetic Materials 241 430–440
- 5[5] Jang Z H, Suh B J, Lascialfari A, Sessoli R and Borsa F 2000 562 557–562
- 6[6] Brem F, Stamm G and Hirt A M 2006 Journal of Applied Physics 99 123906
- 7[7] Brooks R A, Vymazal J, Goldfarb R B Bulte J W M and Aisen P 1998 Magnetic Resonance in Medicine (40) 227–235
- 8[8] Papaefthymiou G C 2010 BBA - General Subjects 1800 886–897
